[HTML][HTML] Oral squamous cell carcinomas: state of the field and emerging directions

Y Tan, Z Wang, M Xu, B Li, Z Huang, S Qin… - International Journal of …, 2023 - nature.com
Oral squamous cell carcinoma (OSCC) develops on the mucosal epithelium of the oral
cavity. It accounts for approximately 90% of oral malignancies and impairs appearance …

Circulating microRNAs as biomarkers in cancer diagnosis

MMH Sohel - Life sciences, 2020 - Elsevier
MicroRNAs (miRNAs) are a group of tiny molecules of 18–22 nucleotide long noncoding
RNA that regulate the post-transcriptional gene expression through translational inhibition …

[HTML][HTML] MicroRNA amplification and detection technologies: opportunities and challenges for point of care diagnostics

VP Dave, TA Ngo, AK Pernestig, D Tilevik, K Kant… - Laboratory …, 2019 - Elsevier
The volume of point of care (POC) testing continues to grow steadily due to the increased
availability of easy-to-use devices, thus making it possible to deliver less costly care closer …

[HTML][HTML] Epigenetic modifications and head and neck cancer: implications for tumor progression and resistance to therapy

RM Castilho, CH Squarize, LO Almeida - International journal of …, 2017 - mdpi.com
Head and neck squamous carcinoma (HNSCC) is the sixth most prevalent cancer and one
of the most aggressive malignancies worldwide. Despite continuous efforts to identify …

[HTML][HTML] Knockdown of SOX2OT inhibits the malignant biological behaviors of glioblastoma stem cells via up-regulating the expression of miR-194-5p and miR-122

R Su, S Cao, J Ma, Y Liu, X Liu, J Zheng, J Chen, L Liu… - Molecular cancer, 2017 - Springer
Background Accumulating evidence has highlighted the potential role of long non-coding
RNAs (lncRNAs) in the biological behaviors of glioblastoma stem cells (GSCs). Here, we …

The emerging roles of miR-125b in cancers

Y Wang, G Zeng, Y Jiang - Cancer management and research, 2020 - Taylor & Francis
MicroRNAs (miRNAs) are endogenous, noncoding, single-stranded RNA molecules of 22
nucleotides in length. MiRNAs have both tumor-suppressive properties and oncogenic …

[HTML][HTML] miR-223-3p inhibits human osteosarcoma metastasis and progression by directly targeting CDH6

Q Ji, X Xu, Q Song, Y Xu, Y Tai, SB Goodman, W Bi… - Molecular Therapy, 2018 - cell.com
Cadherin-6 (CDH6) is aberrantly expressed in cancer and closely associated with tumor
progression. However, the functions of CDH6 in human osteosarcoma and the molecular …

[HTML][HTML] Circulating miR-21 serves as a serum biomarker for hepatocellular carcinoma and correlated with distant metastasis

X Guo, X Lv, X Lv, Y Ma, L Chen, Y Chen - Oncotarget, 2017 - ncbi.nlm.nih.gov
Serum miRNAs have gained great popularity to act as circulating biomarkers of several
cancers. In this study, we aimed to evaluate the diagnostic efficiency of serum miR-21 as …

A comprehensive assessment of the role of miRNAs as biomarkers in gastroenteropancreatic neuroendocrine tumors

A Malczewska, M Kidd, S Matar, B Kos-Kudla… - …, 2018 - karger.com
Background/Aims: A key issue in neuroendocrine neoplasia management is the
identification of blood signatures that specifically define the activity of a cancer or local tumor …

[HTML][HTML] Optical bio-sensing of DNA methylation analysis: an overview of recent progress and future prospects

M Adampourezare, M Hasanzadeh, F Seidi - RSC advances, 2022 - pubs.rsc.org
DNA methylation as one of the most important epigenetic modifications has a critical role in
regulating gene expression and drug resistance in treating diseases such as cancer …